🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

DELTA DESCRIBE: the French Collaborative Project

Recruitingn/aAges 18 Years - anyAllUniversity Hospital, Limoges
NCT05936073 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Our global objective is to draw up a photograph of HDV patients over one year in metropolitan France and identify the barriers of screening and care. The investigator suspects a mismatch between HBV and HDV screening, the first step for specialized care pathway in metropolitan France.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * \>18 years at the second step * HDV RNA positive patients identified at the second step * Patients non opposed to the collection of their data Exclusion Criteria: * Opposition expressed by the patients for the collection of their data
💊

What it tests

  • Patients co-infected HBV/HDV
📍

Where

1 site
Chu Limoges
Limoges, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy